JP2004506420A - 神経変性疾患のための診断剤としての鉄調節タンパク質−２（ｉｒｐ−２） - Google Patents

Info

Publication number

JP2004506420A

JP2004506420A JP2002518256A JP2002518256A JP2004506420A JP 2004506420 A JP2004506420 A JP 2004506420A JP 2002518256 A JP2002518256 A JP 2002518256A JP 2002518256 A JP2002518256 A JP 2002518256A JP 2004506420 A JP2004506420 A JP 2004506420A

Authority

JP

Japan

Prior art keywords

irp

protein

mutant

antibody

wild

Prior art date

2000-08-04

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 208000015122 neurodegenerative disease Diseases 0.000 title claims abstract description 53
• 230000004770 neurodegeneration Effects 0.000 title claims abstract description 52
• 108090001028 Iron regulatory protein 2 Proteins 0.000 title description 387
• 102000004902 Iron regulatory protein 2 Human genes 0.000 title description 364
• 239000000032 diagnostic agent Substances 0.000 title description 3
• 229940039227 diagnostic agent Drugs 0.000 title description 3
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 252
• 238000000034 method Methods 0.000 claims abstract description 171
• 150000007523 nucleic acids Chemical class 0.000 claims abstract description 126
• 229910052742 iron Inorganic materials 0.000 claims abstract description 125
• 102000039446 nucleic acids Human genes 0.000 claims abstract description 106
• 108020004707 nucleic acids Proteins 0.000 claims abstract description 106
• 239000012634 fragment Substances 0.000 claims abstract description 99
• 210000004556 brain Anatomy 0.000 claims abstract description 54
• 208000024827 Alzheimer disease Diseases 0.000 claims abstract description 42
• 208000010877 cognitive disease Diseases 0.000 claims abstract description 30
• 208000027061 mild cognitive impairment Diseases 0.000 claims abstract description 30
• 230000003647 oxidation Effects 0.000 claims abstract description 30
• 238000007254 oxidation reaction Methods 0.000 claims abstract description 30
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims abstract description 26
• 238000002595 magnetic resonance imaging Methods 0.000 claims abstract description 19
• 238000009826 distribution Methods 0.000 claims abstract description 7
• 208000011580 syndromic disease Diseases 0.000 claims abstract description 4
• 101000994818 Agrotis ipsilon Insulin-related peptide 2 Proteins 0.000 claims abstract 14
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 130
• 108090000623 proteins and genes Proteins 0.000 claims description 111
• 102000004169 proteins and genes Human genes 0.000 claims description 100
• 235000018102 proteins Nutrition 0.000 claims description 96
• 239000000523 sample Substances 0.000 claims description 77
• 238000003556 assay Methods 0.000 claims description 64
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 58
• 230000035772 mutation Effects 0.000 claims description 52
• 229920001184 polypeptide Polymers 0.000 claims description 38
• 239000012472 biological sample Substances 0.000 claims description 32
• 235000001014 amino acid Nutrition 0.000 claims description 26
• 230000027455 binding Effects 0.000 claims description 25
• 150000001413 amino acids Chemical class 0.000 claims description 22
• 238000001514 detection method Methods 0.000 claims description 22
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 21
• 102000040430 polynucleotide Human genes 0.000 claims description 21
• 108091033319 polynucleotide Proteins 0.000 claims description 21
• 239000002157 polynucleotide Substances 0.000 claims description 21
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 19
• 125000000539 amino acid group Chemical group 0.000 claims description 18
• 238000006467 substitution reaction Methods 0.000 claims description 18
• 238000009396 hybridization Methods 0.000 claims description 14
• 108091005461 Nucleic proteins Proteins 0.000 claims description 13
• 206010012289 Dementia Diseases 0.000 claims description 12
• 238000012217 deletion Methods 0.000 claims description 9
• 230000037430 deletion Effects 0.000 claims description 9
• 230000002265 prevention Effects 0.000 claims description 8
• 238000010186 staining Methods 0.000 claims description 8
• 238000001262 western blot Methods 0.000 claims description 7
• 238000001943 fluorescence-activated cell sorting Methods 0.000 claims description 6
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
• 230000002159 abnormal effect Effects 0.000 claims description 5
• 238000003317 immunochromatography Methods 0.000 claims description 3
• 239000000816 peptidomimetic Substances 0.000 claims description 3
• 238000012258 culturing Methods 0.000 claims description 2
• 238000001114 immunoprecipitation Methods 0.000 claims description 2
• 241001465754 Metazoa Species 0.000 abstract description 39
• 241000282412 Homo Species 0.000 abstract description 12
• 210000004027 cell Anatomy 0.000 description 104
• 239000012071 phase Substances 0.000 description 58
• 230000014509 gene expression Effects 0.000 description 51
• 210000001519 tissue Anatomy 0.000 description 36
• 230000000694 effects Effects 0.000 description 35
• 230000000295 complement effect Effects 0.000 description 27
• 108020004414 DNA Proteins 0.000 description 25
• 238000008416 Ferritin Methods 0.000 description 24
• 238000004458 analytical method Methods 0.000 description 24
• 239000002773 nucleotide Substances 0.000 description 24
• 125000003729 nucleotide group Chemical group 0.000 description 24
• 229940024606 amino acid Drugs 0.000 description 23
• 102000008857 Ferritin Human genes 0.000 description 22
• 108050000784 Ferritin Proteins 0.000 description 22
• 108090000848 Ubiquitin Proteins 0.000 description 22
• 102000044159 Ubiquitin Human genes 0.000 description 22
• 239000000427 antigen Substances 0.000 description 22
• 108091007433 antigens Proteins 0.000 description 22
• 102000036639 antigens Human genes 0.000 description 22
• 238000003384 imaging method Methods 0.000 description 22
• 239000000047 product Substances 0.000 description 22
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 21
• 230000000875 corresponding effect Effects 0.000 description 21
• 230000002829 reductive effect Effects 0.000 description 20
• 239000013615 primer Substances 0.000 description 19
• 230000008859 change Effects 0.000 description 17
• 239000002299 complementary DNA Substances 0.000 description 17
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
• 241000699666 Mus <mouse, genus> Species 0.000 description 16
• 241000699670 Mus sp. Species 0.000 description 16
• 238000000684 flow cytometry Methods 0.000 description 16
• 238000004519 manufacturing process Methods 0.000 description 16
• 238000005259 measurement Methods 0.000 description 16
• 238000003752 polymerase chain reaction Methods 0.000 description 16
• 210000004369 blood Anatomy 0.000 description 15
• 239000008280 blood Substances 0.000 description 15
• 238000006243 chemical reaction Methods 0.000 description 14
• 230000001419 dependent effect Effects 0.000 description 14
• 238000005516 engineering process Methods 0.000 description 14
• 238000012360 testing method Methods 0.000 description 14
• 239000013604 expression vector Substances 0.000 description 13
• 230000015572 biosynthetic process Effects 0.000 description 12
• 238000006731 degradation reaction Methods 0.000 description 12
• 230000006870 function Effects 0.000 description 12
• 238000011534 incubation Methods 0.000 description 12
• 230000005291 magnetic effect Effects 0.000 description 12
• 239000012528 membrane Substances 0.000 description 12
• 230000004048 modification Effects 0.000 description 12
• 238000012986 modification Methods 0.000 description 12
• 238000012216 screening Methods 0.000 description 12
• 230000009261 transgenic effect Effects 0.000 description 12
• 108700019146 Transgenes Proteins 0.000 description 11
• 230000015556 catabolic process Effects 0.000 description 11
• 235000018417 cysteine Nutrition 0.000 description 11
• 238000003745 diagnosis Methods 0.000 description 11
• 201000010099 disease Diseases 0.000 description 11
• 210000004379 membrane Anatomy 0.000 description 11
• 108020004999 messenger RNA Proteins 0.000 description 11
• 239000013598 vector Substances 0.000 description 11
• 238000002965 ELISA Methods 0.000 description 10
• 241000238631 Hexapoda Species 0.000 description 10
• 230000003321 amplification Effects 0.000 description 10
• 239000000872 buffer Substances 0.000 description 10
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 10
• 150000003278 haem Chemical class 0.000 description 10
• 239000002609 medium Substances 0.000 description 10
• 238000003199 nucleic acid amplification method Methods 0.000 description 10
• 238000011002 quantification Methods 0.000 description 10
• 108091026890 Coding region Proteins 0.000 description 9
• 102000004190 Enzymes Human genes 0.000 description 9
• 108090000790 Enzymes Proteins 0.000 description 9
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 9
• 241000700605 Viruses Species 0.000 description 9
• 235000004279 alanine Nutrition 0.000 description 9
• 239000011230 binding agent Substances 0.000 description 9
• 229940088598 enzyme Drugs 0.000 description 9
• 108020001507 fusion proteins Proteins 0.000 description 9
• 102000037865 fusion proteins Human genes 0.000 description 9
• 238000002372 labelling Methods 0.000 description 9
• 238000002360 preparation method Methods 0.000 description 9
• 230000035945 sensitivity Effects 0.000 description 9
• 238000003786 synthesis reaction Methods 0.000 description 9
• 230000034512 ubiquitination Effects 0.000 description 9
• 238000010798 ubiquitination Methods 0.000 description 9
• 108700028369 Alleles Proteins 0.000 description 8
• -1 Aromatic amino acids Chemical class 0.000 description 8
• 102000004127 Cytokines Human genes 0.000 description 8
• 108090000695 Cytokines Proteins 0.000 description 8
• 239000011324 bead Substances 0.000 description 8
• 239000003153 chemical reaction reagent Substances 0.000 description 8
• 238000007796 conventional method Methods 0.000 description 8
• 239000007850 fluorescent dye Substances 0.000 description 8
• 238000001727 in vivo Methods 0.000 description 8
• 230000009021 linear effect Effects 0.000 description 8
• 238000012544 monitoring process Methods 0.000 description 8
• 210000005087 mononuclear cell Anatomy 0.000 description 8
• 238000012545 processing Methods 0.000 description 8
• XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 8
• 230000004063 proteosomal degradation Effects 0.000 description 8
• 239000000126 substance Substances 0.000 description 8
• 238000013519 translation Methods 0.000 description 8
• 238000009007 Diagnostic Kit Methods 0.000 description 7
• 241000196324 Embryophyta Species 0.000 description 7
• 230000006399 behavior Effects 0.000 description 7
• 238000012512 characterization method Methods 0.000 description 7
• 238000002474 experimental method Methods 0.000 description 7
• 238000000338 in vitro Methods 0.000 description 7
• 230000003834 intracellular effect Effects 0.000 description 7
• 230000001105 regulatory effect Effects 0.000 description 7
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 6
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 6
• 241000700159 Rattus Species 0.000 description 6
• JINBYESILADKFW-UHFFFAOYSA-N aminomalonic acid Chemical compound OC(=O)C(N)C(O)=O JINBYESILADKFW-UHFFFAOYSA-N 0.000 description 6
• 238000003491 array Methods 0.000 description 6
• 238000003776 cleavage reaction Methods 0.000 description 6
• 208000035475 disorder Diseases 0.000 description 6
• 230000005669 field effect Effects 0.000 description 6
• 210000004884 grey matter Anatomy 0.000 description 6
• 210000001320 hippocampus Anatomy 0.000 description 6
• 238000003780 insertion Methods 0.000 description 6
• 230000037431 insertion Effects 0.000 description 6
• 239000000463 material Substances 0.000 description 6
• 239000011859 microparticle Substances 0.000 description 6
• 239000002853 nucleic acid probe Substances 0.000 description 6
• 230000007017 scission Effects 0.000 description 6
• 239000012581 transferrin Substances 0.000 description 6
• 238000005406 washing Methods 0.000 description 6
• 241000283707 Capra Species 0.000 description 5
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
• 241000588724 Escherichia coli Species 0.000 description 5
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
• 108010017480 Hemosiderin Proteins 0.000 description 5
• 241000124008 Mammalia Species 0.000 description 5
• 239000004677 Nylon Substances 0.000 description 5
• 108091034117 Oligonucleotide Proteins 0.000 description 5
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
• 238000007792 addition Methods 0.000 description 5
• 210000005013 brain tissue Anatomy 0.000 description 5
• 238000002405 diagnostic procedure Methods 0.000 description 5
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 5
• 239000000499 gel Substances 0.000 description 5
• 210000004408 hybridoma Anatomy 0.000 description 5
• 230000001965 increasing effect Effects 0.000 description 5
• 230000001939 inductive effect Effects 0.000 description 5
• 230000003278 mimic effect Effects 0.000 description 5
• 239000000203 mixture Substances 0.000 description 5
• 229920001778 nylon Polymers 0.000 description 5
• 230000001590 oxidative effect Effects 0.000 description 5
• 230000005298 paramagnetic effect Effects 0.000 description 5
• 239000013612 plasmid Substances 0.000 description 5
• 102000054765 polymorphisms of proteins Human genes 0.000 description 5
• 229920000136 polysorbate Polymers 0.000 description 5
• 238000004393 prognosis Methods 0.000 description 5
• 241000894007 species Species 0.000 description 5
• 238000013518 transcription Methods 0.000 description 5
• 230000035897 transcription Effects 0.000 description 5
• 241000701161 unidentified adenovirus Species 0.000 description 5
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
• PVKSNHVPLWYQGJ-KQYNXXCUSA-N AMP-PNP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)NP(O)(O)=O)[C@@H](O)[C@H]1O PVKSNHVPLWYQGJ-KQYNXXCUSA-N 0.000 description 4
• 102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 4
• 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 4
• 239000000020 Nitrocellulose Substances 0.000 description 4
• 241000283973 Oryctolagus cuniculus Species 0.000 description 4
• 108010004729 Phycoerythrin Proteins 0.000 description 4
• 101710182846 Polyhedrin Proteins 0.000 description 4
• 108091081024 Start codon Proteins 0.000 description 4
• 102000004338 Transferrin Human genes 0.000 description 4
• 108090000901 Transferrin Proteins 0.000 description 4
• 108010033576 Transferrin Receptors Proteins 0.000 description 4
• 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 4
• 239000002253 acid Substances 0.000 description 4
• 239000002671 adjuvant Substances 0.000 description 4
• 210000004227 basal ganglia Anatomy 0.000 description 4
• 239000002872 contrast media Substances 0.000 description 4
• 230000007547 defect Effects 0.000 description 4
• 238000000326 densiometry Methods 0.000 description 4
• 238000009792 diffusion process Methods 0.000 description 4
• 238000010790 dilution Methods 0.000 description 4
• 239000012895 dilution Substances 0.000 description 4
• 238000002592 echocardiography Methods 0.000 description 4
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
• 230000013632 homeostatic process Effects 0.000 description 4
• 239000003112 inhibitor Substances 0.000 description 4
• 230000010438 iron metabolism Effects 0.000 description 4
• 210000004185 liver Anatomy 0.000 description 4
• 230000007774 longterm Effects 0.000 description 4
• 239000011159 matrix material Substances 0.000 description 4
• 230000007246 mechanism Effects 0.000 description 4
• 230000001404 mediated effect Effects 0.000 description 4
• 229920001220 nitrocellulos Polymers 0.000 description 4
• 230000036542 oxidative stress Effects 0.000 description 4
• 239000002245 particle Substances 0.000 description 4
• 210000005259 peripheral blood Anatomy 0.000 description 4
• 239000011886 peripheral blood Substances 0.000 description 4
• 229920000642 polymer Polymers 0.000 description 4
• 238000000159 protein binding assay Methods 0.000 description 4
• 238000000746 purification Methods 0.000 description 4
• 102000005962 receptors Human genes 0.000 description 4
• 108020003175 receptors Proteins 0.000 description 4
• 238000000926 separation method Methods 0.000 description 4
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
• HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 4
• 239000007787 solid Substances 0.000 description 4
• 239000000243 solution Substances 0.000 description 4
• 230000009870 specific binding Effects 0.000 description 4
• 239000006228 supernatant Substances 0.000 description 4
• 238000000123 temperature gradient gel electrophoresis Methods 0.000 description 4
• 210000001103 thalamus Anatomy 0.000 description 4
• 238000012546 transfer Methods 0.000 description 4
• 210000004885 white matter Anatomy 0.000 description 4
• 208000037259 Amyloid Plaque Diseases 0.000 description 3
• 102000013455 Amyloid beta-Peptides Human genes 0.000 description 3
• 108010090849 Amyloid beta-Peptides Proteins 0.000 description 3
• 238000012935 Averaging Methods 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 241000233866 Fungi Species 0.000 description 3
• 102000005720 Glutathione transferase Human genes 0.000 description 3
• 108010070675 Glutathione transferase Proteins 0.000 description 3
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 3
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 3
• 102000004889 Interleukin-6 Human genes 0.000 description 3
• 108090001005 Interleukin-6 Proteins 0.000 description 3
• 101150010597 Ireb2 gene Proteins 0.000 description 3
• 241000699660 Mus musculus Species 0.000 description 3
• 238000000636 Northern blotting Methods 0.000 description 3
• 108091005804 Peptidases Proteins 0.000 description 3
• 239000004793 Polystyrene Substances 0.000 description 3
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
• 238000002105 Southern blotting Methods 0.000 description 3
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 3
• 150000007513 acids Chemical class 0.000 description 3
• 230000004913 activation Effects 0.000 description 3
• 230000032683 aging Effects 0.000 description 3
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 3
• 238000000540 analysis of variance Methods 0.000 description 3
• 230000006907 apoptotic process Effects 0.000 description 3
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
• 238000010367 cloning Methods 0.000 description 3
• 150000001875 compounds Chemical class 0.000 description 3
• 238000004624 confocal microscopy Methods 0.000 description 3
• 210000000877 corpus callosum Anatomy 0.000 description 3
• 230000002596 correlated effect Effects 0.000 description 3
• 238000003935 denaturing gradient gel electrophoresis Methods 0.000 description 3
• 238000013461 design Methods 0.000 description 3
• BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 3
• 239000006185 dispersion Substances 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 239000002158 endotoxin Substances 0.000 description 3
• 238000011156 evaluation Methods 0.000 description 3
• 238000000605 extraction Methods 0.000 description 3
• 238000002825 functional assay Methods 0.000 description 3
• 230000012010 growth Effects 0.000 description 3
• 230000002209 hydrophobic effect Effects 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• 230000016784 immunoglobulin production Effects 0.000 description 3
• 230000001976 improved effect Effects 0.000 description 3
• 238000010348 incorporation Methods 0.000 description 3
• 229940100601 interleukin-6 Drugs 0.000 description 3
• DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 3
• 238000002955 isolation Methods 0.000 description 3
• 210000000265 leukocyte Anatomy 0.000 description 3
• 229920006008 lipopolysaccharide Polymers 0.000 description 3
• 239000002502 liposome Substances 0.000 description 3
• 230000004807 localization Effects 0.000 description 3
• 229910001629 magnesium chloride Inorganic materials 0.000 description 3
• 210000004962 mammalian cell Anatomy 0.000 description 3
• 210000000337 motor cortex Anatomy 0.000 description 3
• 210000004940 nucleus Anatomy 0.000 description 3
• 238000002515 oligonucleotide synthesis Methods 0.000 description 3
• 230000003287 optical effect Effects 0.000 description 3
• 239000001301 oxygen Substances 0.000 description 3
• 229910052760 oxygen Inorganic materials 0.000 description 3
• 210000002741 palatine tonsil Anatomy 0.000 description 3
• 229920002223 polystyrene Polymers 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 229960003351 prussian blue Drugs 0.000 description 3
• 239000013225 prussian blue Substances 0.000 description 3
• 239000011541 reaction mixture Substances 0.000 description 3
• 230000006798 recombination Effects 0.000 description 3
• 238000011084 recovery Methods 0.000 description 3
• 230000000717 retained effect Effects 0.000 description 3
• 238000010839 reverse transcription Methods 0.000 description 3
• 238000012552 review Methods 0.000 description 3
• 238000012163 sequencing technique Methods 0.000 description 3
• 210000002966 serum Anatomy 0.000 description 3
• 239000007790 solid phase Substances 0.000 description 3
• 238000010561 standard procedure Methods 0.000 description 3
• 238000003860 storage Methods 0.000 description 3
• 239000000758 substrate Substances 0.000 description 3
• 238000011830 transgenic mouse model Methods 0.000 description 3
• 230000003612 virological effect Effects 0.000 description 3
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
• 229920000936 Agarose Polymers 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
• 108090000672 Annexin A5 Proteins 0.000 description 2
• 102000004121 Annexin A5 Human genes 0.000 description 2
• 108010039627 Aprotinin Proteins 0.000 description 2
• 241000894006 Bacteria Species 0.000 description 2
• 241000282472 Canis lupus familiaris Species 0.000 description 2
• 238000001712 DNA sequencing Methods 0.000 description 2
• 241000282326 Felis catus Species 0.000 description 2
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
• 108010024636 Glutathione Proteins 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 108091027305 Heteroduplex Proteins 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• 102100034343 Integrase Human genes 0.000 description 2
• 102000004125 Interleukin-1alpha Human genes 0.000 description 2
• 108010082786 Interleukin-1alpha Proteins 0.000 description 2
• 102000000588 Interleukin-2 Human genes 0.000 description 2
• 108010002350 Interleukin-2 Proteins 0.000 description 2
• 102000004901 Iron regulatory protein 1 Human genes 0.000 description 2
• 108090001025 Iron regulatory protein 1 Proteins 0.000 description 2
• 102000018434 Iron-Regulatory Proteins Human genes 0.000 description 2
• 108010066420 Iron-Regulatory Proteins Proteins 0.000 description 2
• PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 2
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
• 241000270322 Lepidosauria Species 0.000 description 2
• 239000004472 Lysine Substances 0.000 description 2
• 238000012307 MRI technique Methods 0.000 description 2
• 241001467552 Mycobacterium bovis BCG Species 0.000 description 2
• 108010038807 Oligopeptides Proteins 0.000 description 2
• 102000015636 Oligopeptides Human genes 0.000 description 2
• 102000035195 Peptidases Human genes 0.000 description 2
• 108010033276 Peptide Fragments Proteins 0.000 description 2
• 102000007079 Peptide Fragments Human genes 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• 206010035226 Plasma cell myeloma Diseases 0.000 description 2
• 239000004698 Polyethylene Substances 0.000 description 2
• 229920001213 Polysorbate 20 Polymers 0.000 description 2
• 108010029485 Protein Isoforms Proteins 0.000 description 2
• 102000001708 Protein Isoforms Human genes 0.000 description 2
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 229920002684 Sepharose Polymers 0.000 description 2
• 238000012300 Sequence Analysis Methods 0.000 description 2
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
• 208000006011 Stroke Diseases 0.000 description 2
• 238000000692 Student's t-test Methods 0.000 description 2
• PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 2
• 108010006785 Taq Polymerase Proteins 0.000 description 2
• 241000723873 Tobacco mosaic virus Species 0.000 description 2
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
• 241000700618 Vaccinia virus Species 0.000 description 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
• 230000005856 abnormality Effects 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• 230000000996 additive effect Effects 0.000 description 2
• MGSKVZWGBWPBTF-UHFFFAOYSA-N aebsf Chemical compound NCCC1=CC=C(S(F)(=O)=O)C=C1 MGSKVZWGBWPBTF-UHFFFAOYSA-N 0.000 description 2
• VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 2
• 230000004075 alteration Effects 0.000 description 2
• 230000001640 apoptogenic effect Effects 0.000 description 2
• 229960004405 aprotinin Drugs 0.000 description 2
• 238000000211 autoradiogram Methods 0.000 description 2
• 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 2
• 230000001580 bacterial effect Effects 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 230000002146 bilateral effect Effects 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 235000020958 biotin Nutrition 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 230000000903 blocking effect Effects 0.000 description 2
• 238000009835 boiling Methods 0.000 description 2
• 210000000170 cell membrane Anatomy 0.000 description 2
• 230000036755 cellular response Effects 0.000 description 2
• 210000003710 cerebral cortex Anatomy 0.000 description 2
• 230000002759 chromosomal effect Effects 0.000 description 2
• 210000000349 chromosome Anatomy 0.000 description 2
• 238000012790 confirmation Methods 0.000 description 2
• 238000012631 diagnostic technique Methods 0.000 description 2
• 230000005292 diamagnetic effect Effects 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• 239000003814 drug Substances 0.000 description 2
• 210000003743 erythrocyte Anatomy 0.000 description 2
• 230000001747 exhibiting effect Effects 0.000 description 2
• MURGITYSBWUQTI-UHFFFAOYSA-N fluorescin Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC=C(O)C=C2OC2=CC(O)=CC=C21 MURGITYSBWUQTI-UHFFFAOYSA-N 0.000 description 2
• 238000010363 gene targeting Methods 0.000 description 2
• 238000010353 genetic engineering Methods 0.000 description 2
• 210000004602 germ cell Anatomy 0.000 description 2
• 230000013595 glycosylation Effects 0.000 description 2
• 238000006206 glycosylation reaction Methods 0.000 description 2
• 239000005090 green fluorescent protein Substances 0.000 description 2
• 239000001963 growth medium Substances 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 229940025294 hemin Drugs 0.000 description 2
• BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 2
• 230000000971 hippocampal effect Effects 0.000 description 2
• 230000005661 hydrophobic surface Effects 0.000 description 2
• 238000010191 image analysis Methods 0.000 description 2
• 238000003018 immunoassay Methods 0.000 description 2
• 238000010166 immunofluorescence Methods 0.000 description 2
• 230000002163 immunogen Effects 0.000 description 2
• 238000003364 immunohistochemistry Methods 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 230000006698 induction Effects 0.000 description 2
• ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 238000002347 injection Methods 0.000 description 2
• 239000007924 injection Substances 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 2
• 229960002725 isoflurane Drugs 0.000 description 2
• 108010076401 isopeptidase Proteins 0.000 description 2
• 210000003140 lateral ventricle Anatomy 0.000 description 2
• 238000007834 ligase chain reaction Methods 0.000 description 2
• 210000004698 lymphocyte Anatomy 0.000 description 2
• 210000002540 macrophage Anatomy 0.000 description 2
• 239000006249 magnetic particle Substances 0.000 description 2
• 239000003550 marker Substances 0.000 description 2
• 229930182817 methionine Natural products 0.000 description 2
• 238000013508 migration Methods 0.000 description 2
• 230000005012 migration Effects 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 238000010172 mouse model Methods 0.000 description 2
• 238000007837 multiplex assay Methods 0.000 description 2
• 201000000050 myeloid neoplasm Diseases 0.000 description 2
• 230000000626 neurodegenerative effect Effects 0.000 description 2
• 238000010855 neuropsychological testing Methods 0.000 description 2
• 230000009022 nonlinear effect Effects 0.000 description 2
• 230000006911 nucleation Effects 0.000 description 2
• 238000010899 nucleation Methods 0.000 description 2
• 238000002966 oligonucleotide array Methods 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 238000010647 peptide synthesis reaction Methods 0.000 description 2
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
• 230000000770 proinflammatory effect Effects 0.000 description 2
• 235000019833 protease Nutrition 0.000 description 2
• 238000003908 quality control method Methods 0.000 description 2
• 238000003127 radioimmunoassay Methods 0.000 description 2
• 230000009257 reactivity Effects 0.000 description 2
• 238000005215 recombination Methods 0.000 description 2
• 238000011160 research Methods 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 230000028327 secretion Effects 0.000 description 2
• 239000006152 selective media Substances 0.000 description 2
• VUFNRPJNRFOTGK-UHFFFAOYSA-M sodium;1-[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]oxy-2,5-dioxopyrrolidine-3-sulfonate Chemical group [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)C1CCC(CN2C(C=CC2=O)=O)CC1 VUFNRPJNRFOTGK-UHFFFAOYSA-M 0.000 description 2
• 210000004989 spleen cell Anatomy 0.000 description 2
• 238000007619 statistical method Methods 0.000 description 2
• 125000001424 substituent group Chemical group 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 230000002123 temporal effect Effects 0.000 description 2
• 210000003478 temporal lobe Anatomy 0.000 description 2
• CNHYKKNIIGEXAY-UHFFFAOYSA-N thiolan-2-imine Chemical group N=C1CCCS1 CNHYKKNIIGEXAY-UHFFFAOYSA-N 0.000 description 2
• 235000002374 tyrosine Nutrition 0.000 description 2
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
• 241001515965 unidentified phage Species 0.000 description 2
• 238000011144 upstream manufacturing Methods 0.000 description 2
• 210000003462 vein Anatomy 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• FHLXUWOHGKLDNF-UHFFFAOYSA-N (2-nitrophenyl) carbonochloridate Chemical compound [O-][N+](=O)C1=CC=CC=C1OC(Cl)=O FHLXUWOHGKLDNF-UHFFFAOYSA-N 0.000 description 1
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
• ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
• SCVJRXQHFJXZFZ-KVQBGUIXSA-N 2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione Chemical compound C1=2NC(N)=NC(=S)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 SCVJRXQHFJXZFZ-KVQBGUIXSA-N 0.000 description 1
• XMTQQYYKAHVGBJ-UHFFFAOYSA-N 3-(3,4-DICHLOROPHENYL)-1,1-DIMETHYLUREA Chemical compound CN(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XMTQQYYKAHVGBJ-UHFFFAOYSA-N 0.000 description 1
• AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
• OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
• FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
• TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
• WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
• 206010000117 Abnormal behaviour Diseases 0.000 description 1
• 102000013563 Acid Phosphatase Human genes 0.000 description 1
• 108010051457 Acid Phosphatase Proteins 0.000 description 1
• 102100029457 Adenine phosphoribosyltransferase Human genes 0.000 description 1
• 108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 108091093088 Amplicon Proteins 0.000 description 1
• 102000004881 Angiotensinogen Human genes 0.000 description 1
• 108090001067 Angiotensinogen Proteins 0.000 description 1
• 241000219194 Arabidopsis Species 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 239000000592 Artificial Cell Substances 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 206010003497 Asphyxia Diseases 0.000 description 1
• 206010003591 Ataxia Diseases 0.000 description 1
• 206010003694 Atrophy Diseases 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 241001203868 Autographa californica Species 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 229920002799 BoPET Polymers 0.000 description 1
• 206010068975 Bone atrophy Diseases 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 101710132601 Capsid protein Proteins 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 241000701489 Cauliflower mosaic virus Species 0.000 description 1
• 102100032231 Caveolae-associated protein 2 Human genes 0.000 description 1
• 108050005259 Caveolae-associated protein 2 Proteins 0.000 description 1
• 241000700198 Cavia Species 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 229920001661 Chitosan Polymers 0.000 description 1
• 241000195585 Chlamydomonas Species 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 101100185881 Clostridium tetani (strain Massachusetts / E88) mutS2 gene Proteins 0.000 description 1
• 101710094648 Coat protein Proteins 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 108020004635 Complementary DNA Proteins 0.000 description 1
• 241000759568 Corixa Species 0.000 description 1
• 241000186216 Corynebacterium Species 0.000 description 1
• 241000701022 Cytomegalovirus Species 0.000 description 1
• 150000008574 D-amino acids Chemical class 0.000 description 1
• 101150074155 DHFR gene Proteins 0.000 description 1
• 230000004544 DNA amplification Effects 0.000 description 1
• 230000005778 DNA damage Effects 0.000 description 1
• 231100000277 DNA damage Toxicity 0.000 description 1
• 239000003155 DNA primer Substances 0.000 description 1
• 239000003298 DNA probe Substances 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
• 206010061818 Disease progression Diseases 0.000 description 1
• 201000010374 Down Syndrome Diseases 0.000 description 1
• 208000017701 Endocrine disease Diseases 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 239000004593 Epoxy Substances 0.000 description 1
• 241000701959 Escherichia virus Lambda Species 0.000 description 1
• IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical group OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
• 108091029865 Exogenous DNA Proteins 0.000 description 1
• 108010074860 Factor Xa Proteins 0.000 description 1
• 229910015400 FeC13 Inorganic materials 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 229920002527 Glycogen Polymers 0.000 description 1
• 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 102000005548 Hexokinase Human genes 0.000 description 1
• 108700040460 Hexokinases Proteins 0.000 description 1
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 1
• 101000766306 Homo sapiens Serotransferrin Proteins 0.000 description 1
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
• 101100321817 Human parvovirus B19 (strain HV) 7.5K gene Proteins 0.000 description 1
• 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
• 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 1
• 108700002232 Immediate-Early Genes Proteins 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
• 108020005350 Initiator Codon Proteins 0.000 description 1
• 241000018427 Iphisa elegans Species 0.000 description 1
• 238000008575 Iron Assay Methods 0.000 description 1
• 239000005909 Kieselgur Substances 0.000 description 1
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• 150000008575 L-amino acids Chemical class 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 239000000232 Lipid Bilayer Substances 0.000 description 1
• 108010047357 Luminescent Proteins Proteins 0.000 description 1
• 102000006830 Luminescent Proteins Human genes 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 101710125418 Major capsid protein Proteins 0.000 description 1
• 241001599018 Melanogaster Species 0.000 description 1
• 208000026139 Memory disease Diseases 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 1
• 102000010645 MutS Proteins Human genes 0.000 description 1
• 108010038272 MutS Proteins Proteins 0.000 description 1
• 102000006386 Myelin Proteins Human genes 0.000 description 1
• 108010083674 Myelin Proteins Proteins 0.000 description 1
• 239000005041 Mylar™ Substances 0.000 description 1
• MDSUKZSLOATHMH-UHFFFAOYSA-N N-L-leucyl-L-valine Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(O)=O MDSUKZSLOATHMH-UHFFFAOYSA-N 0.000 description 1
• 206010028851 Necrosis Diseases 0.000 description 1
• 206010028980 Neoplasm Diseases 0.000 description 1
• 208000012902 Nervous system disease Diseases 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• 101710141454 Nucleoprotein Proteins 0.000 description 1
• 108700026244 Open Reading Frames Proteins 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• 241000282520 Papio Species 0.000 description 1
• 208000018737 Parkinson disease Diseases 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
• 241000235648 Pichia Species 0.000 description 1
• 241000276498 Pollachius virens Species 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 101710083689 Probable capsid protein Proteins 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 102100022805 Protein Wnt-2 Human genes 0.000 description 1
• 102220472129 Protein Wnt-2_C23A_mutation Human genes 0.000 description 1
• 235000014443 Pyrus communis Nutrition 0.000 description 1
• 108020004518 RNA Probes Proteins 0.000 description 1
• 239000003391 RNA probe Substances 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
• 108010073443 Ribi adjuvant Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 241000220317 Rosa Species 0.000 description 1
• 241000235070 Saccharomyces Species 0.000 description 1
• 229920005654 Sephadex Polymers 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 241000700584 Simplexvirus Species 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
• 108010092262 T-Cell Antigen Receptors Proteins 0.000 description 1
• 210000001744 T-lymphocyte Anatomy 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 108090000190 Thrombin Proteins 0.000 description 1
• 102000006601 Thymidine Kinase Human genes 0.000 description 1
• 108020004440 Thymidine kinase Proteins 0.000 description 1
• 108010001244 Tli polymerase Proteins 0.000 description 1
• 206010044565 Tremor Diseases 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 206010044688 Trisomy 21 Diseases 0.000 description 1
• GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
• 108091023045 Untranslated Region Proteins 0.000 description 1
• 206010046865 Vaccinia virus infection Diseases 0.000 description 1
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
• 240000008042 Zea mays Species 0.000 description 1
• 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
• 229910021536 Zeolite Inorganic materials 0.000 description 1
• 238000002835 absorbance Methods 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 230000009471 action Effects 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 238000007844 allele-specific PCR Methods 0.000 description 1
• PMMURAAUARKVCB-UHFFFAOYSA-N alpha-D-ara-dHexp Natural products OCC1OC(O)CC(O)C1O PMMURAAUARKVCB-UHFFFAOYSA-N 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 150000001408 amides Chemical group 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 229940126575 aminoglycoside Drugs 0.000 description 1
• 229960003896 aminopterin Drugs 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 238000000137 annealing Methods 0.000 description 1
• 230000000340 anti-metabolite Effects 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 210000000628 antibody-producing cell Anatomy 0.000 description 1
• 229940100197 antimetabolite Drugs 0.000 description 1
• 239000002256 antimetabolite Substances 0.000 description 1
• 238000003782 apoptosis assay Methods 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 1
• 229910052786 argon Inorganic materials 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 238000003149 assay kit Methods 0.000 description 1
• 210000001130 astrocyte Anatomy 0.000 description 1
• 230000003140 astrocytic effect Effects 0.000 description 1
• 239000012298 atmosphere Substances 0.000 description 1
• 238000000559 atomic spectroscopy Methods 0.000 description 1
• 230000037444 atrophy Effects 0.000 description 1
• 238000000376 autoradiography Methods 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 239000007640 basal medium Substances 0.000 description 1
• 230000003542 behavioural effect Effects 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 238000004159 blood analysis Methods 0.000 description 1
• 230000017531 blood circulation Effects 0.000 description 1
• 210000004204 blood vessel Anatomy 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 230000006931 brain damage Effects 0.000 description 1
• 231100000874 brain damage Toxicity 0.000 description 1
• 208000029028 brain injury Diseases 0.000 description 1
• KQNZDYYTLMIZCT-KQPMLPITSA-N brefeldin A Chemical compound O[C@@H]1\C=C\C(=O)O[C@@H](C)CCC\C=C\[C@@H]2C[C@H](O)C[C@H]21 KQNZDYYTLMIZCT-KQPMLPITSA-N 0.000 description 1
• JUMGSHROWPPKFX-UHFFFAOYSA-N brefeldin-A Natural products CC1CCCC=CC2(C)CC(O)CC2(C)C(O)C=CC(=O)O1 JUMGSHROWPPKFX-UHFFFAOYSA-N 0.000 description 1
• 238000010804 cDNA synthesis Methods 0.000 description 1
• VULFYOXOVPJBLV-UHFFFAOYSA-N carbonochloridic acid;1-hydroxypyrrolidine-2,5-dione Chemical compound OC(Cl)=O.ON1C(=O)CCC1=O VULFYOXOVPJBLV-UHFFFAOYSA-N 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 238000007444 cell Immobilization Methods 0.000 description 1
• 239000008004 cell lysis buffer Substances 0.000 description 1
• 210000003855 cell nucleus Anatomy 0.000 description 1
• 230000003833 cell viability Effects 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 230000030570 cellular localization Effects 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 210000001638 cerebellum Anatomy 0.000 description 1
• 206010008118 cerebral infarction Diseases 0.000 description 1
• 210000004720 cerebrum Anatomy 0.000 description 1
• 239000005081 chemiluminescent agent Substances 0.000 description 1
• 238000000546 chi-square test Methods 0.000 description 1
• 230000001713 cholinergic effect Effects 0.000 description 1
• 239000012916 chromogenic reagent Substances 0.000 description 1
• 239000013611 chromosomal DNA Substances 0.000 description 1
• 230000001149 cognitive effect Effects 0.000 description 1
• 239000013065 commercial product Substances 0.000 description 1
• 238000010835 comparative analysis Methods 0.000 description 1
• 238000012875 competitive assay Methods 0.000 description 1
• 230000009137 competitive binding Effects 0.000 description 1
• 230000009918 complex formation Effects 0.000 description 1
• 238000010668 complexation reaction Methods 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 239000006059 cover glass Substances 0.000 description 1
• 239000002577 cryoprotective agent Substances 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
• 150000001945 cysteines Chemical class 0.000 description 1
• 238000003568 cytokine secretion assay Methods 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000007423 decrease Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 230000003412 degenerative effect Effects 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 238000003936 denaturing gel electrophoresis Methods 0.000 description 1
• 229940009976 deoxycholate Drugs 0.000 description 1
• KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
• 230000008021 deposition Effects 0.000 description 1
• 230000001066 destructive effect Effects 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
• 230000005750 disease progression Effects 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• 238000009510 drug design Methods 0.000 description 1
• 238000001035 drying Methods 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 230000004064 dysfunction Effects 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 210000001671 embryonic stem cell Anatomy 0.000 description 1
• 210000002257 embryonic structure Anatomy 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 229960002413 ferric citrate Drugs 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 108091006047 fluorescent proteins Proteins 0.000 description 1
• 102000034287 fluorescent proteins Human genes 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• 210000004055 fourth ventricle Anatomy 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 210000005153 frontal cortex Anatomy 0.000 description 1
• 230000005021 gait Effects 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 238000012254 genetic linkage analysis Methods 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 101150117187 glmS gene Proteins 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 235000004554 glutamine Nutrition 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 229940096919 glycogen Drugs 0.000 description 1
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
• 239000010931 gold Substances 0.000 description 1
• 229910052737 gold Inorganic materials 0.000 description 1
• 239000011544 gradient gel Substances 0.000 description 1
• 201000010235 heart cancer Diseases 0.000 description 1
• 208000019622 heart disease Diseases 0.000 description 1
• 208000024348 heart neoplasm Diseases 0.000 description 1
• CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
• 238000005534 hematocrit Methods 0.000 description 1
• 210000005154 hemibrain Anatomy 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
• 238000000265 homogenisation Methods 0.000 description 1
• 238000002744 homologous recombination Methods 0.000 description 1
• 230000006801 homologous recombination Effects 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
• 230000003100 immobilizing effect Effects 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000002649 immunization Methods 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 238000003365 immunocytochemistry Methods 0.000 description 1
• 230000000951 immunodiffusion Effects 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 239000012133 immunoprecipitate Substances 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 238000007901 in situ hybridization Methods 0.000 description 1
• 238000010249 in-situ analysis Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 230000006882 induction of apoptosis Effects 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 238000011081 inoculation Methods 0.000 description 1
• 229910052500 inorganic mineral Inorganic materials 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 238000009830 intercalation Methods 0.000 description 1
• 238000010212 intracellular staining Methods 0.000 description 1
• 150000002505 iron Chemical class 0.000 description 1
• 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
• NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
• 101150066555 lacZ gene Proteins 0.000 description 1
• 239000004816 latex Substances 0.000 description 1
• 229920000126 latex Polymers 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
• 230000005415 magnetization Effects 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 235000009973 maize Nutrition 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 230000006996 mental state Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 239000000693 micelle Substances 0.000 description 1
• HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 210000000274 microglia Anatomy 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 239000011707 mineral Substances 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000037230 mobility Effects 0.000 description 1
• 102000035118 modified proteins Human genes 0.000 description 1
• 108091005573 modified proteins Proteins 0.000 description 1
• 238000001823 molecular biology technique Methods 0.000 description 1
• 239000003068 molecular probe Substances 0.000 description 1
• 239000012514 monoclonal antibody product Substances 0.000 description 1
• 230000000877 morphologic effect Effects 0.000 description 1
• 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
• 210000002200 mouth mucosa Anatomy 0.000 description 1
• 101150013854 mutS gene Proteins 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
• 229960000951 mycophenolic acid Drugs 0.000 description 1
• 210000005012 myelin Anatomy 0.000 description 1
• 239000005445 natural material Substances 0.000 description 1
• 230000017074 necrotic cell death Effects 0.000 description 1
• 230000001338 necrotic effect Effects 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 210000002682 neurofibrillary tangle Anatomy 0.000 description 1
• 238000002610 neuroimaging Methods 0.000 description 1
• 230000000926 neurological effect Effects 0.000 description 1
• 238000010984 neurological examination Methods 0.000 description 1
• 230000002981 neuropathic effect Effects 0.000 description 1
• 230000003557 neuropsychological effect Effects 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 201000003077 normal pressure hydrocephalus Diseases 0.000 description 1
• 238000007826 nucleic acid assay Methods 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 210000004248 oligodendroglia Anatomy 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 150000002482 oligosaccharides Polymers 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 230000010355 oscillation Effects 0.000 description 1
• 230000005408 paramagnetism Effects 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 239000008188 pellet Substances 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 210000004976 peripheral blood cell Anatomy 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 230000008823 permeabilization Effects 0.000 description 1
• 230000010363 phase shift Effects 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 230000007505 plaque formation Effects 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 229920001983 poloxamer Polymers 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 229920000447 polyanionic polymer Polymers 0.000 description 1
• 229920000573 polyethylene Polymers 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 229920005862 polyol Polymers 0.000 description 1
• 150000003077 polyols Chemical class 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 230000001144 postural effect Effects 0.000 description 1
• 239000000276 potassium ferrocyanide Substances 0.000 description 1
• 238000011533 pre-incubation Methods 0.000 description 1
• 239000002987 primer (paints) Substances 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 210000004129 prosencephalon Anatomy 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 238000003498 protein array Methods 0.000 description 1
• 108060006633 protein kinase Proteins 0.000 description 1
• 230000009145 protein modification Effects 0.000 description 1
• XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1
• 208000020016 psychiatric disease Diseases 0.000 description 1
• 210000002637 putamen Anatomy 0.000 description 1
• 210000002804 pyramidal tract Anatomy 0.000 description 1
• 238000004445 quantitative analysis Methods 0.000 description 1
• 239000011535 reaction buffer Substances 0.000 description 1
• 238000003259 recombinant expression Methods 0.000 description 1
• 210000000463 red nucleus Anatomy 0.000 description 1
• BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
• 239000002461 renin inhibitor Substances 0.000 description 1
• 229940086526 renin-inhibitors Drugs 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 239000011347 resin Substances 0.000 description 1
• 229920005989 resin Polymers 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 102200158768 rs121908410 Human genes 0.000 description 1
• 102220040233 rs79219465 Human genes 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 238000005464 sample preparation method Methods 0.000 description 1
• 238000010187 selection method Methods 0.000 description 1
• 238000004092 self-diagnosis Methods 0.000 description 1
• 230000009919 sequestration Effects 0.000 description 1
• 235000004400 serine Nutrition 0.000 description 1
• 239000000741 silica gel Substances 0.000 description 1
• 229910002027 silica gel Inorganic materials 0.000 description 1
• 229910052814 silicon oxide Inorganic materials 0.000 description 1
• 238000004088 simulation Methods 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 238000001542 size-exclusion chromatography Methods 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 210000004927 skin cell Anatomy 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 210000001082 somatic cell Anatomy 0.000 description 1
• 210000004092 somatosensory cortex Anatomy 0.000 description 1
• 125000006850 spacer group Chemical group 0.000 description 1
• 238000000264 spin echo pulse sequence Methods 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 230000010473 stable expression Effects 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 230000003068 static effect Effects 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 230000004960 subcellular localization Effects 0.000 description 1
• 201000009032 substance abuse Diseases 0.000 description 1
• 231100000736 substance abuse Toxicity 0.000 description 1
• 208000011117 substance-related disease Diseases 0.000 description 1
• 210000003523 substantia nigra Anatomy 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 230000002195 synergetic effect Effects 0.000 description 1
• 238000001308 synthesis method Methods 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 238000010189 synthetic method Methods 0.000 description 1
• 238000012353 t test Methods 0.000 description 1
• XOGGUFAVLNCTRS-UHFFFAOYSA-N tetrapotassium;iron(2+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] XOGGUFAVLNCTRS-UHFFFAOYSA-N 0.000 description 1
• 230000001225 therapeutic effect Effects 0.000 description 1
• 125000004035 thiopropyl group Chemical group [H]SC([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
• 210000000211 third ventricle Anatomy 0.000 description 1
• 235000008521 threonine Nutrition 0.000 description 1
• 229960004072 thrombin Drugs 0.000 description 1
• 210000001541 thymus gland Anatomy 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 238000005820 transferase reaction Methods 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 238000009827 uniform distribution Methods 0.000 description 1
• 208000007089 vaccinia Diseases 0.000 description 1
• 238000010200 validation analysis Methods 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 210000000264 venule Anatomy 0.000 description 1
• 238000012795 verification Methods 0.000 description 1
• 230000001720 vestibular Effects 0.000 description 1
• 229920002554 vinyl polymer Polymers 0.000 description 1
• 238000003260 vortexing Methods 0.000 description 1
• 230000003442 weekly effect Effects 0.000 description 1
• 239000010457 zeolite Substances 0.000 description 1